top of page
Contact Us
Contact Us

More case studies

A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025.

Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client

A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial.

Comparator Sourcing for a Phase II Ophthalmology Study

CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries

How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time

Export of expensive comparators from Europe to China with first leg documents and streamlined approach

CSI’s seamless comparator export to China

CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay

Global Device Distribution

How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market

Rescuing a Global Biotech's Oncology Study with Cetuximab

How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea

Rescuing a Biotech’s Oncology Trial with Lenvatinib

How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price

Delivering €1 million Savings for Pembrolizumab

How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments

Global Jakavi Study

How the flexibility and initiative of CSI’s Quality team overcame challenges to ensure timely product supply for a partner’s ongoing clinical trial

A Quality Solution to Clinical Trial Supply

How CSI delivered mission impossible: sourcing specific tested batches of an expensive oncology product from several European markets

Oncology Product Batch Hunting

How CSI used its scientific expertise at the protocol stage to provide flexibility in sourcing strategy and ensure high volumes of a single product were supplied on time to multiple countries

Delivering Comparators for a Global Allergy Study

  • Maintaining Cost Stability – The client needed price consistency despite market fluctuations over multiple years.

  • Expiry Date Optimization – Ensuring the longest possible shelf life to offset packaging delays.

  • Uninterrupted Supply Chain – Stock replenishment had to be seamless, avoiding disruptions and putting patients at risk

  • Large-Scale Procurement – Sourcing high volumes in one batch while maintaining quality and compliance.

--- -fORTitle-- --- --- --- ----

Strategic Bulk Sourcing: CSI successfully procured thousands of units in USA and Europe in very large batches, securing availability and reducing procurement cycles.

  • Pricing Stability Over 3 Years: Thanks to strong, long-term relationships with strategic partners, CSI maintained consistent pricing despite market shifts.

  • Direct Procurement from Manufacturer: By sourcing, CSI ensured a short, secure, and reliable supply chain with minimal risk.

Results & Impact

  • Reliable, uninterrupted supply for the client's clinical trial needs

  • Optimized expiry dates to maximize product usability post-packaging

  • Cost-effective procurement, reducing financial uncertainty

At CSI, we deliver strategic, secure and cost-effective clinical supply solutions—ensuring trial success through efficient sourcing and supply chain expertise.

A global listed Biotech company required large quantities of Eylea Pre-Filled Syringes (PFS) sourced across both the EU and USA. Their priorities included:

  • Relatively Stable pricing over a 2-3 year period

  • Best possible expiry dates to accommodate packaging timelines (losing 6-8 weeks in the process)

  • Ensuring continuous supply by replenishing stock before expiry (~14-16 months)

  • Bulk procurement in single large batches for efficiency in regular intervals

Case Study

Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies

Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies.

The client required consistent pricing over multiple years, regardless of market fluctuations, alongside seamless stock replenishment to maintain an uninterrupted supply chain and protect patient safety. Additionally, they needed large-scale procurement with optimized expiry dates, ensuring maximum shelf life and compliance without compromising quality.

CSI secured large batches of Eylea across the USA and Europe, ensuring consistent supply and stable pricing through strong partnerships and direct manufacturer sourcing. This minimized risks, optimized expiry dates, and delivered cost-effective, uninterrupted supply—supporting successful clinical trials.

A global biotech company required substantial quantities of Eylea Pre-Filled Syringes (PFS) sourced from both the EU and USA, prioritizing stable pricing over a 2–3 year period. They aimed for optimal expiry dates to account for packaging timelines that typically consumed 6–8 weeks, and needed to ensure a continuous supply by replenishing stock approximately every 14–16 months. Additionally, bulk procurement in single large batches at regular intervals was crucial for efficiency and effectiveness.

Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements

Contact us 

bottom of page